title: Continued rapid growth in (68) Ga applications: update 2013 to June 2014.
abstract: The worldwide utilization of (68) Ga-radionuclide for the fundamental research and clinical applications is growing exponentially. A broad range of (68) Ga-based imaging agents has been explored during recent years. The development of new clinically useful agents is encouraged by many factors; for example, increasing role of positron emission tomography (PET) in nuclear medicine, discovery of new biomarkers, accessibility of (68) Ga, and establishment of PET radiopharmaceutical regulation and legislation. The focus of this review resides on the reports regarding (68) Ga-related research and applications published during 2013 to June 2014.
authors.affiliation: Preclinical PET Platform, Department of Medicinal Chemistry, Uppsala University, SE-75183, Uppsala, Sweden; Department of Radiology, Oncology and Radiation Science, Uppsala University, SE-75285, Uppsala, Sweden; PET-Centre, Centre for Medical Imaging, Uppsala University Hospital, SE-75185, Uppsala, Sweden.
authors.forename: Irina
authors.initials: I
authors.lastname: Velikyan
mesh_terms: D000818:Animals; D003952:Diagnostic Imaging; D005710:Gallium Radioisotopes / Q000737:chemistry / Q000600:supply & distribution; D006801:Humans; D011854:Radiochemistry; D012926:Social Control, Formal
chemical_list: D005710:Gallium Radioisotopes
keywords: 68Ga; chemistry; peptide; perfusion; positron emission tomography; receptor targeting; ventilation